RAPT vs WFC · $132.1M cap vs P/E 15, rev $22.62B
RAPT Therapeutics Inc (RAPT) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
Latest reported WFC revenue for 2026-06-30 was $22.62B. Net income was $6.41B. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
RAPT currently screens at market cap $132.1M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the RAPT and WFC stock pages for the full models.
Not investment advice.